Full Text
Health Economic Evaluation Of Elective Cardioversion Of Atrial Fibrillation With Rivaroxaban Versus Vitamin K Oral Antagonists

Abstract

Authors

MS Jacobs LA de Jong MJ Postma RG Tieleman M van Hulst

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×